Upgrade to SI Premium - Free Trial

DepoMed Inc (DEPO) PT Lowered to $9 at Piper Jaffray

August 8, 2017 8:23 AM
Piper Jaffray lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $9.00 (from $10.00) while maintaining a Neutral rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles